Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02983825 · ClinicalTrials.gov registry record · NA

Impact of CPAP Level on V/Q Mismatch in Premature Infants

A NA study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT02983825 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02983825, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

Continuous positive airway pressure (CPAP) is used in premature infants to maintain lungs open and facilitate gas exchange. When ventilation/perfusion (V/Q) mismatch is present, areas of the lung that are open for gas exchange do not match up with the areas of the lung that are receiving blood for gas exchange. This study measure the responsiveness of V/Q mismatch to changes in the amount (or level) of CPAP.

Interventions

  • DEVICE Continuous positive airway pressure (CPAP); level changes

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2017-02-01
Est. Completion 2020-02-13
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT02983825

The ClinicalTrials.gov registry entry for NCT02983825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Continuous positive airway pressure (CPAP); level changes is the first listed.

NCT02983825 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02983825 about?

NCT02983825 is a clinical study titled "Impact of CPAP Level on V/Q Mismatch in Premature Infants". Continuous positive airway pressure (CPAP) is used in premature infants to maintain lungs open and facilitate gas exchange. When ventilation/perfusion (V/Q) mismatch is present, areas of the lung that are open for gas exchange do not match up with the areas of the lung that are receiving blood for g...

What is the current status of trial NCT02983825?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-02-01. Estimated completion is 2020-02-13.

What interventions are being tested in trial NCT02983825?

The interventions under investigation include: Continuous positive airway pressure (CPAP); level changes (DEVICE).

Who is sponsoring clinical trial NCT02983825?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.